🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for FemTech

Benchmark revenue and EBITDA valuation multiples for public comps like Olema Pharmaceuticals, Abbott India, Curves Holdings Co., Organon and InMode.

Company	EV	EV/LTM Revenue	EV/LTM EBITDA
Hologic	$16.9B	4.1x	12.4x
Neurocrine Biosciences	$11.4B	4.0x	17.3x
Organon	$10.1B	1.6x	5.2x
Abbott India	$6.0B	8.0x	29.1x
Olema Pharmaceuticals	$1.5B	n/a	-8.8x
Jiangsu Bioperfectus	$645M	n/a	n/a
Curves Holdings Co.	$433M	1.7x	7.6x
InMode	$359M	1.0x	3.8x
Context Therapeutics	$135M	n/a	n/a
Elutia	$69.3M	3.7x	-7.8x
Applied BioCode	$60.7M	n/a	n/a
Veru	$21.6M	n/a	n/a
Movano	$14.6M	n/a	n/a
Futura Medical	$5.3M	n/a	n/a
Dare Bioscience	$4.1M	5.5x	n/a
Atossa Therapeutics	-$15.8M	n/a	n/a